Francoise Revillion

Summary

Affiliation: Centre Oscar Lambret
Country: France

Publications

  1. pmc High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
    Piotr Tymoszuk
    Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innrain 80 82, 6020 Innsbruck, Austria
    BMC Cancer 14:257. 2014
  2. pmc SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases
    Jocelyne Jacquemier
    Institut Paoli Calmettes, Biopathology Department, 232 Bd Ste Marguerite, 13009, Marseille, France
    BMC Cancer 13:351. 2013
  3. pmc Favorable prognostic value of SOCS2 and IGF-I in breast cancer
    Michael C Haffner
    Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
    BMC Cancer 7:136. 2007
  4. ncbi request reprint Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion
    F Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre de lutte contre le cancer Oscar Lambret, Lille France
    Int J Biol Markers 23:10-7. 2008
  5. ncbi request reprint ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis
    F Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, BP 307, 59020 Lille Cedex, France
    Ann Oncol 19:73-80. 2008
  6. ncbi request reprint Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Département de Sénologie, Laboratoire de Cytologie et d Anatomie Pathologiques, Centre Oscar Lambret, Lille, France
    Clin Cancer Res 12:2088-94. 2006
  7. ncbi request reprint Prognostic value of ERM gene expression in human primary breast cancers
    Anne Chotteau-Lelievre
    Unité Mixte de Recherche 8117 Centre National de la Recherché Scientifique, Régulation Transcriptionnelle au cours de la Tumorigenèse Mammaire, Institut de Biologie de Lille, Institut Pasteur de Lille, Lille, France
    Clin Cancer Res 10:7297-303. 2004
  8. ncbi request reprint mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 309, 59020 Lille, France
    Anticancer Res 23:1455-60. 2003
  9. pmc Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer
    Francoise Revillion
    Contrôle de la progression des cancers hormono dépendants, Laboratoire d Oncologie Moléculaire Humaine, Centre Régional de Lutte Contre le Cancer Oscar Lambret, Lille, France
    Int J Cancer 124:638-43. 2009
  10. ncbi request reprint Multiplex single-nucleotide primer extension analysis to simultaneously detect eleven BRCA1 mutations in breast cancer families
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 307, 59020 Lille Cedex, France
    Clin Chem 50:203-6. 2004

Collaborators

  • Jacques Bonneterre
  • Anne Chotteau-Lelievre
  • Yvan De Launoit
  • Catherine Mullié
  • Alain Duhamel
  • E Leblanc
  • S Giard
  • Marie Christine Baranzelli
  • Gilles Freiss
  • Jean Philippe Peyrat
  • Piotr Tymoszuk
  • Jocelyne Jacquemier
  • Clothilde Lindet
  • Elisabeth Muller-Holzner
  • Wolfgang Doppler
  • Marie Bénédicte Romond
  • Mohamed Hebbar
  • V Samouelian
  • Michael C Haffner
  • Hubert Hackl
  • Heidi Fiegl
  • Pornpimol Charoentong
  • Zlatko Trajanoski
  • Peter Obrist
  • Rita Spilka
  • Frederique Penault-Llorca
  • Benjamin Esterni
  • Ludovic Lacroix
  • Jean Marc Guinebretiere
  • Gaetan MacGrogan
  • Ivan Bieche
  • Sophie Vacher
  • Pierre Jean Lamy
  • Frederique Spyratos
  • Yves Marie Robin
  • Marie Joelle Mozziconacci
  • Sophie Krieger
  • Marie Christine Mathieu
  • Magali Lacroix Triki
  • Marie Pierre Chenard
  • Luc Xerri
  • Cécile Blanc Fournier
  • Laurent Arnould
  • Sarab Lizard
  • Delphine Loussouarn
  • Jacqueline Lehmann-Che
  • Anne Vincent Salomon
  • Alexander Valent
  • Martine Antoine
  • Frederic Bibeau
  • Michèle Legrain
  • Geneviève Portefaix
  • Philippe Bertheau
  • Aline Seaume
  • Patricia De Cremoux
  • Isabelle Hostein
  • Valérie Lhotellier
  • Louis Hornez
  • Daniel Izard
  • Jean Pierre Triboulet
  • Alain Duhamel
  • Christian Libersa
  • Stéphanie Truant
  • Claire Giraud
  • Olivier Romano
  • Michel Colavizza
  • François René Pruvot
  • Antoine Adenis
  • N Alloy
  • J P Peyrat
  • V Lhotellier
  • Barbara Petridou
  • Christian Marth
  • Günter Daxenbichler
  • Jean Phillipe Peyrat
  • B Vandewalle
  • A Draoui
  • J Lefebvre
  • L Hornez

Detail Information

Publications17

  1. pmc High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
    Piotr Tymoszuk
    Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innrain 80 82, 6020 Innsbruck, Austria
    BMC Cancer 14:257. 2014
    ..Additionally, we evaluated the interrelationship of these parameters and their significance for predicting disease outcome...
  2. pmc SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases
    Jocelyne Jacquemier
    Institut Paoli Calmettes, Biopathology Department, 232 Bd Ste Marguerite, 13009, Marseille, France
    BMC Cancer 13:351. 2013
    ....
  3. pmc Favorable prognostic value of SOCS2 and IGF-I in breast cancer
    Michael C Haffner
    Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
    BMC Cancer 7:136. 2007
    ..The present study is aimed to elucidate the clinicopathological features associated with SOCS1, SOCS2, SOCS3, CIS and IGF-I expression in breast cancer...
  4. ncbi request reprint Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion
    F Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre de lutte contre le cancer Oscar Lambret, Lille France
    Int J Biol Markers 23:10-7. 2008
    ....
  5. ncbi request reprint ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis
    F Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, BP 307, 59020 Lille Cedex, France
    Ann Oncol 19:73-80. 2008
    ..The aim of this study is to provide an expression profile of ErbB/HER ligands in breast cancer. We analysed the relationships with their receptors, the bio-pathological features and prognosis...
  6. ncbi request reprint Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Département de Sénologie, Laboratoire de Cytologie et d Anatomie Pathologiques, Centre Oscar Lambret, Lille, France
    Clin Cancer Res 12:2088-94. 2006
    ..We analyzed their relations with the classical prognostic factors and with survival to establish their links with breast cancer...
  7. ncbi request reprint Prognostic value of ERM gene expression in human primary breast cancers
    Anne Chotteau-Lelievre
    Unité Mixte de Recherche 8117 Centre National de la Recherché Scientifique, Régulation Transcriptionnelle au cours de la Tumorigenèse Mammaire, Institut de Biologie de Lille, Institut Pasteur de Lille, Lille, France
    Clin Cancer Res 10:7297-303. 2004
    ..This study demonstrates for the first time that ERM gene expression is an independent adverse prognostic factor for overall survival in breast cancer patients...
  8. ncbi request reprint mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 309, 59020 Lille, France
    Anticancer Res 23:1455-60. 2003
    ..In the present paper, we simultaneously quantified, for the first time, the mRNA expression of these four receptors in response to estradiol and 4-hydroxy-tamoxifen in the prototypical ER-positive human breast cancer cell line MCF-7...
  9. pmc Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer
    Francoise Revillion
    Contrôle de la progression des cancers hormono dépendants, Laboratoire d Oncologie Moléculaire Humaine, Centre Régional de Lutte Contre le Cancer Oscar Lambret, Lille, France
    Int J Cancer 124:638-43. 2009
    ..In conjunction with our mechanistic studies, this finding identifies PTPL1 as an important regulatory element of human breast tumor aggressiveness and sensitivity to treatments such as antiestrogens and antiaromatase...
  10. ncbi request reprint Multiplex single-nucleotide primer extension analysis to simultaneously detect eleven BRCA1 mutations in breast cancer families
    Francoise Revillion
    Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 307, 59020 Lille Cedex, France
    Clin Chem 50:203-6. 2004
  11. ncbi request reprint Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers
    Clothilde Lindet
    Département de Sénologie, Centre Oscar Lambret, Lille France
    Int J Biol Markers 27:e111-7. 2012
    ..The aim of this study was to analyze the relationships between PR isoforms and the network of the HER/ErbB receptors and ligands in breast cancer...
  12. ncbi request reprint Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer
    V Samouelian
    Laboratory of Human Molecular Oncology, Centre Oscar Lambret, Lille France
    Int J Biol Markers 23:74-82. 2008
    ..Our results should encourage us in continue to investigate a greater number of patients, including patients with histologically involved nodes...
  13. ncbi request reprint Intestinal colonization with bifidobacteria affects the expression of galectins in extraintestinal organs
    Marie Bénédicte Romond
    Laboratoire de Bactériologie Virologie EA3610, Faculte des Sciences Pharmaceutiques et Biologiques, Lille, France
    FEMS Immunol Med Microbiol 55:85-92. 2009
    ....
  14. ncbi request reprint E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer
    Mohamed Hebbar
    Department of Medical Oncology, University Hospital, Lille, France
    Eur J Cancer 45:1871-6. 2009
    ..This polymorphism detection may permit better selection of patients suitable for adjuvant therapy, especially among those with stage II disease...
  15. ncbi request reprint Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors
    A Draoui
    Laboratoire d Endocrinologie Experimentale, Centre Oscar Lambret, Lille, France
    Anticancer Res 11:677-80. 1991
    ....
  16. ncbi request reprint Cell kinetics (SAMBA 200) of estradiol stimulated long-term phenol red withdrawn cultured breast cancer cells
    F Revillion
    Laboratoire d Endocrinologie Experimentale, Centre Oscar Lambret, Lille, France
    Anticancer Res 10:1067-70. 1990
    ..The lack of effect of estradiol stimulation on the growth of MCF-7 cells maintained several months without phenol red is not thus a consequence of cell cycle perturbations...
  17. ncbi request reprint Functional beta-adrenergic receptors in breast cancer cells
    B Vandewalle
    Laboratoire d Endocrinologie Experimentale, Centre Oscar Lambret, Lille, France
    J Cancer Res Clin Oncol 116:303-6. 1990
    ....